Lia DeGroot

A group of for­mer top FDA of­fi­cials are ask­ing the Supreme Court to up­hold the agency’s reg­u­la­tion of the abor­tion pill mifepri­s­tone, ac­cord­ing to an

In­dus­try groups, mem­bers of Con­gress and state leg­is­la­tures are among the wave of par­ties that asked the Supreme Court on Tues­day to pre­serve the FDA’s

Sen. Tam­my Bald­win (D-WI) is the lat­est law­mak­er to call on in­haler man­u­fac­tur­ers to re­move what the FTC has deemed im­prop­er­ly list­ed patents from the

The FDA pub­lished draft guid­ance on Mon­day di­rect­ing clin­i­cal tri­al spon­sors to in­clude race and eth­nic­i­ty in­for­ma­tion on their pro­posed prod­uct la­bel­ing, and to add

An­titrust and merg­er en­force­ment in Eu­rope has led to fair­er prices for med­i­cines and kept mar­kets com­pet­i­tive over the past sev­er­al years, ac­cord­ing to a

Per­haps no in­dus­try in health­care has seen its po­lit­i­cal for­tunes change faster than PBMs over the last two years. It’s been just more than a

WASH­ING­TON — Sen­ate HELP Com­mit­tee Chair Bernie Sanders (I-VT) to­day ex­pressed op­ti­mism that he has the votes nec­es­sary to sub­poe­na the CEOs of John­son &

Sen­a­tors on both sides of the aisle are seek­ing to ease mar­ket en­try for gener­ics and biosim­i­lars with a new bill that would cre­ate guardrails

This past week, Sen. Ron John­son (R-WI) pressed pub­lic health of­fi­cials over con­cerns that Covid-19 shots from cer­tain lots are as­so­ci­at­ed with a greater risk

Sen. Amy Klobuchar (D-MN) is pres­sur­ing six phar­ma com­pa­nies to re­move im­prop­er­ly list­ed patents from the FDA’s Or­ange Book by the end of the month,